Zydus Lifesciences is trading 1.20% upper at Rs 913.80 as compared to its last closing price. Zydus Lifesciences has been trading in the price range of 919.65 & 902.90. Zydus Lifesciences has given -7.10% in this year & 2.74% in the last 5 days. Zydus Lifesciences has TTM P/E ratio 21.59 as compared to the sector P/E of 24.50.There are 27 analysts who have initiated coverage on Zydus Lifesciences. There are 3 analysts who have given it a strong buy rating & 9 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 1,023.50 Crores in its last quarter.Listed peers of Zydus Lifesciences include Dr Reddys Laboratories (-0.86%), Lupin (-0.91%), Zydus Lifesciences (1.20%).The Mutual Fund holding in Zydus Lifesciences was at 6.36% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Zydus Lifesciences was at 7.31% in 31 Mar 2025. The FII holding has decreased from the last quarter.
Updated on May 19, 2025, 07:44 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Dr Reddys Laboratories | Moderately Bullish | 1,219.95 | -0.86 | 1,01,947.35 | 18.11 | 3.05 | 0.65 | 2.34 |
Lupin | Bearish | 2,049.55 | -0.91 | 93,585.84 | 28.85 | 5.49 | 0.39 | 11.80 |
Zydus Lifesciences | Neutral | 913.80 | 1.20 | 91,873.47 | 23.81 | 4.58 | 0.33 | 0.13 |
Abbott India | Bullish | 30,550.00 | -0.04 | 65,112.14 | 45.91 | 15.34 | 1.55 | 3.73 |
Alkem Laboratories | Moderately Bullish | 5,386.05 | 3.16 | 64,398.31 | 34.71 | 6.05 | 0.80 | 2.22 |
Meeting Date | Purpose |
---|---|
2025-05-20 | Audited Results & Final Dividend |
2025-02-05 | Quarterly Results |
2024-11-12 | Quarterly Results |
2024-08-09 | Quarterly Results |
2024-05-17 | Audited Results & Final Dividend |
Zydus Lifesciences is trading at 913.80 as on Mon May 19 2025 07:44:34. This is 1.20% upper as compared to its previous closing price of 903.00.
The market capitalization of Zydus Lifesciences is 91873.47 Cr as on Mon May 19 2025 07:44:34.
The average broker rating on Zydus Lifesciences is Hold. The breakup of analyst rating is given below -
The 52 wk high for Zydus Lifesciences is 1323.90 whereas the 52 wk low is 797.05
Zydus Lifesciences can be analyzed on the following key metrics -
Zydus Lifesciences reported a net profit of 3859.50 Cr in 2024.
The Mutual Fund Shareholding was 6.36% at the end of 31 Mar 2025.